A novel longitudinal rank-sum test for multiple primary endpoints in clinical trials: Applications to neurodegenerative disorders.
Publication
, Preprint
Xu, X; Ghosh, D; Luo, S
May 13, 2024
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Xu, X., Ghosh, D., & Luo, S. (2024). A novel longitudinal rank-sum test for multiple primary endpoints in clinical trials: Applications to neurodegenerative disorders. https://doi.org/10.1101/2023.06.24.23291858
Xu, Xiaoming, Dhrubajyoti Ghosh, and Sheng Luo. “A novel longitudinal rank-sum test for multiple primary endpoints in clinical trials: Applications to neurodegenerative disorders.,” May 13, 2024. https://doi.org/10.1101/2023.06.24.23291858.
Xu, Xiaoming, et al. A novel longitudinal rank-sum test for multiple primary endpoints in clinical trials: Applications to neurodegenerative disorders. 13 May 2024. Pubmed, doi:10.1101/2023.06.24.23291858.